Circulating interleukins and risk of colorectal cancer: a Mendelian randomization study

References

• Lim EB, Oh HS, Kim KC, et al. Identification and functional validation of HLA-C as a potential gene involved in colorectal cancer in the Korean population. BMC Genomics. 2022;23(1):261. doi: 10.1186/s12864-022-08509-5.
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014–1022. doi: 10.1038/ni.2703.
   PubMed Web of Science ®Google Scholar
• Askoura M, Abbas HA, Al Sadoun H, et al. Elevated levels of IL-33, IL-17 and IL-25 indicate the progression from chronicity to hepatocellular carcinoma in hepatitis C virus patients. Pathogens. 2022;11(1):57. doi: 10.3390/pathogens11010057.
   PubMed Web of Science ®Google Scholar
• Braumüller H, Mauerer B, Andris J, et al. The cytokine network in colorectal cancer: implications for new treatment strategies. Cells. 2022;12(1):138. doi: 10.3390/cells12010138.
   PubMed Web of Science ®Google Scholar
• Leonard WJ, Lin J-X, O’Shea JJ. The γc family of cytokines: basic biology to therapeutic ramifications. Immunity. 2019;50(4):832–850. doi: 10.1016/j.immuni.2019.03.028.
   PubMed Web of Science ®Google Scholar
• Zhu X, Liang R, Lan T. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer. J ImmunoTher Cancer. 2022;10(9):e004219. doi: 10.1136/jitc-2021-004219.
   PubMed Web of Science ®Google Scholar
• Sun Q, Shang Y, Sun F, et al. Interleukin-6 promotes epithelial-mesenchymal transition and cell invasion through integrin β6 upregulation in colorectal cancer. Oxid Med Cell Longev. 2020;2020:8032187. doi: 10.1155/2020/8032187.
   PubMed Web of Science ®Google Scholar
• Ye D, Liu H, Zhao G, et al. LncGMDS-AS1 promotes the tumorigenesis of colorectal cancer through HuR-STAT3/Wnt axis. Cell Death Dis. 2023;14(2):165. doi: 10.1038/s41419-023-05700-8.
   PubMed Web of Science ®Google Scholar
• Albrecht HC, Gustavus D, Schwanemann J, et al. Generation of colon cancer-derived tumor-infiltrating T cells (TILs) for ­adoptive cell therapy. Cytotherapy. 2023;25(5):537–547. doi: 10.1016/j.jcyt.2023.01.009.
   PubMed Web of Science ®Google Scholar
• Acevedo-León D, Gómez-Abril SÁ, Sanz-García P, et al. The role of oxidative stress, tumor and inflammatory markers in colorectal cancer patients: a one-year follow-up study. Redox Biol. 2023;62:102662. doi: 10.1016/j.redox.2023.102662.
   PubMed Web of Science ®Google Scholar
• Shibabaw T, Teferi B, Ayelign B. The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: as a means of prognosis and therapeutic target. Front Immunol. 2023;14:1094823. doi: 10.3389/fimmu.2023.1094823.
   PubMed Web of Science ®Google Scholar
• Alzahrani FA, Ahmed F, Sharma M, et al. Investigating the pathogenic SNPs in BLM helicase and their biological consequences by computational approach. Sci Rep. 2020;10(1):12377. doi: 10.1038/s41598-020-69033-8.
   PubMed Web of Science ®Google Scholar
• Schaub MA, Kaplow IM, Sirota M, et al. A classifier-based approach to identify genetic similarities between diseases. Bioinformatics. 2009;25(12):i21–i29. doi: 10.1093/bioinformatics/btp226.
   PubMed Web of Science ®Google Scholar
• Liang YY, Chen J, Peng M, et al. Association between sleep duration and metabolic syndrome: linear and nonlinear mendelian randomization analyses. J Transl Med. 2023;21(1):90. doi: 10.1186/s12967-023-03920-2.
   PubMed Web of Science ®Google Scholar
• Li J, Li C, Huang Y, et al. Mendelian randomization analyses in ocular disease: a powerful approach to causal inference with human genetic data. J Transl Med. 2022;20(1):621. doi: 10.1186/s12967-022-03822-9.
   PubMed Web of Science ®Google Scholar
• Folkersen L, Gustafsson S, Wang Q, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab. 2020;2(10):1135–1148. doi: 10.1038/s42255-020-00287-2.
   PubMedGoogle Scholar
• Zhao H, Jin X. Causal associations between dietary antioxidant vitamin intake and lung cancer: a Mendelian randomization study. Front Nutr. 2022;9:965911. doi: 10.3389/fnut.2022.965911.
   PubMed Web of Science ®Google Scholar
• Lim AJW, Tyniana CT, Lim LJ, et al. Robust SNP-based prediction of rheumatoid arthritis through machine-learning-optimized polygenic risk score. J Transl Med. 21;92.
   PubMed Web of Science ®Google Scholar
• Bou Sleiman M, Jha P, Houtkooper R, et al. The gene-regulatory footprint of aging highlights conserved central regulators. Cell Rep. 2020;32(13):108203. doi: 10.1016/j.celrep.2020.108203.
   PubMed Web of Science ®Google Scholar
• Von Essen MR, Søndergaard HB, Petersen ERS, et al. IL-6, IL-12, and IL-23 STAT-Pathway genetic risk and responsiveness of lymphocytes in patients with multiple sclerosis. Cells. 2019;8(3):285. doi: 10.3390/cells8030285.
   PubMed Web of Science ®Google Scholar
• Kühnapfel A, Horn K, Klotz U, et al. Genetic regulation of cytokine response in patients with acute community-acquired pneumonia. Genes. 2022;13(1):111. doi: 10.3390/genes13010111.
   PubMed Web of Science ®Google Scholar
• Wang QJ, Shen YE, Wang X, et al. Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice. Aging. 2020;12(1):628–649.
   PubMedGoogle Scholar
• Ye X, Li J, Cheng Y, et al. Genome-wide association study of resistance to stripe rust (Puccinia striiformis f. sp. tritici) in Sichuan wheat. BMC Plant Biol. 2019;19(1):147. doi: 10.1186/s12870-019-1764-4.
   PubMedGoogle Scholar
• Zhuang H, Han J, Cheng L, et al. A positive causal influence of IL-18 levels on the risk of T2DM: a Mendelian randomization study. Front Genet. 2019;10:295.
   PubMed Web of Science ®Google Scholar
• Li BH, Yan SY, Luo LS, et al. Ten interleukins and risk of prostate cancer. Front Oncol. 2023;13:1108633. doi: 10.3389/fonc.2023.1108633.
   PubMedGoogle Scholar
• Yi M, Zhao W, Fei Q, et al. Causal analysis between altered levels of interleukins and obstructive sleep apnea. Front Immunol. 2022;13:888644. doi: 10.3389/fimmu.2022.888644.
   PubMed Web of Science ®Google Scholar
• Yuan S, Li X, Lin A, et al. Interleukins and rheumatoid arthritis: bi-directional Mendelian randomization investigation. Semin Arthritis Rheum. 2022;53:151958. doi: 10.1016/j.semarthrit.2022.151958.
   PubMed Web of Science ®Google Scholar
• Lu H, Wu PF, Zhang W, et al. Circulating interleukins and risk of multiple sclerosis: a Mendelian randomization study. Front Immunol. 2021;12:647588. doi: 10.3389/fimmu.2021.647588.
   PubMed Web of Science ®Google Scholar
• Yuan S, Lin A, He QQ, et al. Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: a two-sample Mendelian randomization study. Int J Cardiol. 2020;313:99–104. doi: 10.1016/j.ijcard.2020.03.053.
   PubMed Web of Science ®Google Scholar
• Cui G, Liu H, Laugsand JB. Endothelial cells-directed angiogenesis in colorectal cancer: interleukin as the mediator and pharmacological target. Int Immunopharmacol. 2023;114:109525. doi: 10.1016/j.intimp.2022.109525.
   PubMed Web of Science ®Google Scholar
• Li W, Chen F, Gao H, et al. Cytokine concentration in peripheral blood of patients with colorectal cancer. Front Immunol. 2023;14:1175513. doi: 10.3389/fimmu.2023.1175513.
   PubMed Web of Science ®Google Scholar
• Liu QQ, Li CM, Fu LN, et al. Enterotoxigenic Bacteroides fragilis induces the stemness in colorectal cancer via upregulating histone demethylase JMJD2B. Gut Microbes. 2020;12(1):1788900. doi: 10.1080/19490976.2020.1788900.
   PubMedGoogle Scholar
• Trimaglio G, Tilkin-Mariamé AF, Feliu V, et al. Colon-specific immune microenvironment regulates cancer progression versus rejection. Oncoimmunology. 2020;9(1):1790125. doi: 10.1080/2162402X.2020.1790125.
   PubMed Web of Science ®Google Scholar
• Huang C, Yang G, Jiang T, et al. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro. Neoplasma. 2011;58(5):396–405. doi: 10.4149/neo_2011_05_396.
   PubMed Web of Science ®Google Scholar
• Kim B, Seo Y, Kwon JH, et al. IL-6 and IL-8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor. Mol Carcinog. 2021;60(3):188–200. doi: 10.1002/mc.23283.
   PubMed Web of Science ®Google Scholar
• Liu Y, Han Z P, Zhang S S, et al. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem. 2011;286(28):25007–25015. doi: 10.1074/jbc.M110.213108.
   PubMed Web of Science ®Google Scholar
• Xu J, Qian J, Zhang W, et al. LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL‑6 and TNF‑α. Oncol Rep. 2019;41(4):2389–2395. doi: 10.3892/or.2019.7034.
   PubMed Web of Science ®Google Scholar
• Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol. 2006;6(8):595–601. doi: 10.1038/nri1901.
   PubMed Web of Science ®Google Scholar
• Taylor ES, McCall JL, Shen S, et al. Prognostic roles for IL-2-producing and CD69+ T cell subsets in colorectal cancer patients. Int J Cancer. 2018;143(8):2008–2016.
   PubMed Web of Science ®Google Scholar
• Masters SL, Dunne A, Subramanian SL, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol. 2010; 11(10):897–904.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang Z, Deng B, et al. Interleukin 1β/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy. Oncol Rep. 2020;43(3):908–918. doi: 10.3892/or.2020.7475.
   PubMed Web of Science ®Google Scholar
• Xie Q, Shen WW, Zhong J, et al. Lipopolysaccharide/adenosine triphosphate induces IL‑1β and IL-18 secretion through the NLRP3 inflammasome in RAW264.7 murine macrophage cells. Int J Mol Med. 2014;34(1):341–349. doi: 10.3892/ijmm.2014.1755.
   PubMed Web of Science ®Google Scholar
• Feng X, Zhang Z, Sun P, et al. Interleukin-18 is a prognostic marker and plays a tumor suppressive role in colon cancer. Dis Markers. 2020;2020:6439614. doi: 10.1155/2020/6439614.
   PubMed Web of Science ®Google Scholar
• Chen KQ, Li D Z, Chen Z B, et al. Quanzhenyiqitang reverses LPS-Induced inflammation via inhibiting PYK2/p38MAPK/HDAC2/CK2 signaling pathway in rat alveolar macrophage. Evid Based Complement Alternat Med. 2022;2022:7857022. doi: 10.1155/2022/7857022.
   PubMed Web of Science ®Google Scholar
• Ackermann A, Lafferton B, Plotz G, et al. Expression and secretion of the pro‑inflammatory cytokine IL‑8 is increased in colorectal cancer cells following the knockdown of non‑erythroid spectrin αII. Int J Oncol. 2020;56(6):1551–1564. doi: 10.3892/ijo.2020.5026.
   PubMed Web of Science ®Google Scholar
• Van Damme J, Van Beeumen J, Opdenakker G, et al. A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J Exp Med. 1988;167(4):1364–1376. doi: 10.1084/jem.167.4.1364.
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84(4):1045–1049. doi: 10.1172/JCI114265.
   PubMed Web of Science ®Google Scholar
• D’Agostino G, García-Cuesta EM, Gomariz RP, et al. The multilayered complexity of the chemokine receptor system. Biochem Biophys Res Commun. 2020;528(2):347–358. doi: 10.1016/j.bbrc.2020.02.120.
   PubMed Web of Science ®Google Scholar
• Olivera I, Sanz-Pamplona R, Bolaños E, et al. A therapeutically actionable protumoral axis of cytokines involving IL-8, TNFα, and IL-1β. Cancer Discov. 2022;12(9):2140–2157. doi: 10.1158/2159-8290.CD-21-1115.
   PubMed Web of Science ®Google Scholar
• Teijeira A, Garasa S, Ochoa MC, et al. IL8, neutrophils, and NETs in a collusion against cancer immunity and immunotherapy. Clin Cancer Res. 2021;27(9):2383–2393. doi: 10.1158/1078-0432.CCR-20-1319.
   PubMed Web of Science ®Google Scholar
• Waugh DJJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735–6741. doi: 10.1158/1078-0432.CCR-07-4843.
   PubMed Web of Science ®Google Scholar
• Alfaro C, Sanmamed MF, Rodríguez-Ruiz ME, et al. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat Rev. 2017;60:24–31. doi: 10.1016/j.ctrv.2017.08.004.
   PubMed Web of Science ®Google Scholar